These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38118370)

  • 1. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
    Benavent D; Carmona L; Lopez-Olivo MA; Hill CL; Westrich-Robertson T; Goel N; Strand V; Shea B; Grosskleg S; Leong A; Hofstetter C; Bingham C; Meyer D; Constien D; Berthelsen DB; Schultz G; de Groot I; Weiner J; Mather K; de Wit M; Böhm P; Cembalo SM; Tugwell P; Bruera S; Suarez-Almazor ME
    Semin Arthritis Rheum; 2024 Feb; 64():152343. PubMed ID: 38118370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
    Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
    J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session.
    Chapman LS; Jones J; Redmond AC; Flurey CA; Richards P; Hofstetter C; Smith TO; Arnold JB; Hannan MT; Maxwell LJ; Menz HB; Shea B; Golightly YM; Tugwell P; Beaton D; Conaghan PG; Helliwell PS; Siddle HJ
    Semin Arthritis Rheum; 2023 Aug; 61():152210. PubMed ID: 37156170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative.
    Bruera S; Carmona L; Lopez-Olivo MA; Westrich-Robertson T; March L; Negron JB; Christensen R; Strand V; Ingegnoli F; Goel N; Shea B; Tugwell P; Leong A; Bingham CO; Hill CL; Suarez-Almazor ME
    Semin Arthritis Rheum; 2021 Oct; 51(5):1113-1116. PubMed ID: 34446270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
    Décary S; de Wit M; Naye F; Barton JL; Fraenkel L; Li LC; Brooks P; Stacey D; Maxwell LJ; Campbell W; Hofstetter C; Voshaar M; Meara A; Christensen R; Boonen A; Suarez-Almazor ME; Meade T; March L; Jull JE; Alten R; Morgan EM; Stewart Hazlewood G; Barber CEH; Guillemin F; El-Miedany Y; Mittoo S; Robertson TW; Bartlett SJ; Singh JA; Mannion M; Nasef SI; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Berthelsen DB; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Beaton D; Shea B; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Lee RR; Umaefulam V; Monti S; Abaza N; Schultz G; Stones S; Gossec L; Nielsen SM; Cavallo S; Srinivasalu H; Constien D; Evans V; Tugwell P; Toupin-April K
    Semin Arthritis Rheum; 2024 Apr; 65():152381. PubMed ID: 38306813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
    Bartlett SJ; Bykerk VP; Cooksey R; Choy EH; Alten R; Christensen R; Furst DE; Guillemin F; Halls S; Hewlett S; Leong AL; Lyddiatt A; March L; Montie P; Orbai AM; Pohl C; Voshaar MS; Woodworth TG; Bingham CO
    J Rheumatol; 2015 Nov; 42(11):2185-9. PubMed ID: 25684764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
    Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.
    Bingham CO; Alten R; Bartlett SJ; Bykerk VP; Brooks PM; Choy E; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Montie P; Pohl C; Sanderson TC; Strand V; Woodworth TG;
    J Rheumatol; 2011 Aug; 38(8):1751-8. PubMed ID: 21807797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.
    Maxwell LJ; Beaton DE; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit M; Gossec L; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1014-1020. PubMed ID: 30770502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
    Toupin-April K; Décary S; de Wit M; Meara A; Barton JL; Fraenkel L; Li LC; Brooks P; Shea B; Stacey D; Légaré F; Lydiatt A; Hofstetter C; Proulx L; Christensen R; Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Guillemin F; Beaton D; El-Miedany Y; Mittoo S; Westrich Robertson T; Bartlett SJ; Singh JA; Mannion M; Nasef SI; de Souza S; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Carrott D; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Umaefulam V; Monti S; Melburn C; Abaza N; Schultz K; Stones S; Kiwalkar S; Srinivasalu H; Constien D; King LK; Tugwell P
    Semin Arthritis Rheum; 2021 Jun; 51(3):593-600. PubMed ID: 33892937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis.
    Lopez-Olivo MA; Negrón JB; Zogala RJ; Carmona L; Criner K; Goel N; Gonzalez-Lopez L; Ingegnoli F; Leong A; March L; Shea B; Strand V; Tugwell P; Westrich-Robertson T; Zamora NV; Christensen R; Suarez-Almazor ME
    J Rheumatol; 2019 Sep; 46(9):1164-1167. PubMed ID: 30824644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.
    Maxwell LJ; Jones C; Bingham CO; Boers M; Boonen A; Choy E; Christensen R; Conaghan PG; D'Agostino MA; Doria AS; Grosskleg S; Hill CL; Hofstetter C; Horgan B; Kroon F; Leung YY; Mackie S; Meara A; Shea BJ; Simon LS; Touma Z; Tugwell P; Wells GA; Beaton DE
    Semin Arthritis Rheum; 2024 Jun; 66():152423. PubMed ID: 38460282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
    Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO
    J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
    Nielsen W; Strand V; Simon LS; Parodis I; Kim AHJ; Desai M; Enman Y; Wallace D; Chaichian Y; Navarra S; Aranow C; MacKay M; Trotter K; Tayer-Shifman OE; Duarte-Garcia A; Shan Tam L; Ugarte-Gil MF; PonsEstel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Papachristos D; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Howe A; Kia BN; Bonilla D; Thumboo J; Mosca M; Aringer M; Johnson SR; Drucker AM; Morand E; Bruce I; Touma Z;
    Semin Arthritis Rheum; 2024 Apr; 65():152380. PubMed ID: 38281467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.